| Pharmaceutical active ingredients: |
| Guaiacol Carbonate |
| Available forms, composition and doses of Tussophob: |
| N / A |
| Tussophob medical category: |
| Human:Expectorants, antiseptics, local anesthetics |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| ATCICD-10 |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Unidentified Pharmaceutical Company |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Tussol | Guaifenesin; Ipecacuanha; Oxomemazine Hydrochloride; Potassium Iodide; Sodium Benzoate | Instituto Brasileiro de Especialid Farmac |
| Tussol | Ammonium Chloride; Ammonium Glycyrrhizinate; Guaifenesin; Liquorice | Nycomed |
| Tussolvina | Nepinalone Hydrochloride | Pfizer |
| Tussophedrine | Codeine Phosphate; Ephedrine Hydrochloride; Sodium Benzoate; Sulfogaiacol | Trima Pharmaceuticals |
| Tussophedrine New Formula | Dextromethorphan Hydrobromide; Ephedrine Hydrochloride; Potassium Guaiacolsulfonate; Sodium Benzoate | Trima Pharmaceuticals |
| Tussoret | Codeine Phosphate | Fujisawa |
| Tussoret Tag / Nacht | Codeine Phosphate | Fujisawa |
| Tussoretard Capsules | Codeine Phosphate; Diphenhydramine Hydrochloride; DL-N-Methylephedrine Hydrochloride; Noscapine | Fujisawa |
| Tussoretard Liquid | Codeine Phosphate; Noscapine | Fujisawa |
| Tussoretardin | Carbetapentane Citrate; Diphenhydramine Hydrochloride; Methylephedrine Hydrochloride | Fujisawa |